Gazzah, A., Lin, C., Ruiter, G., Lee, K. H., Spira, A., Garrido, P., Sanchez-Gastaldo, A., Felip, E., Hiret, S., Patel, S. B., Wermke, M., Spigel, D. R., Rieke, D. T., Mazières, J., Nguyen, D., Bernardo, M., Fabre, C., Xu, J., Masson, A. D., Luo, Y. (2026). First-in-human dose-escalation study of the selective EGFR/HER2 exon 20 inhibitor PFL-721 in patients with locally advanced or metastatic NSCLC.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.8619